A Critique of Dr. Richard Guttler's Beliefs About Hypothyroidism

FRF Homepage | Directors, Officers, Advisors | Our Mission | Our Current Study
How We Spend Donated Money
| Published FRF-Sponsored Studies | What We Have Accomplished
In Memoriam | How to Donate to FRF | How to Contact Us | Clarifications: Replacement Studies

drlowe.com Homepage

Addenda to:
Dr. Richard Guttler and the "Real Thyroid Experts":
Their False and Potentially Harmful Beliefs


by Dr. John C. Lowe
Diplomate: American Academy of Pain Management
Director of Research: Fibromyalgia Research Foundation


1007 Pearl St., Suite 280 Boulder, CO 80032 USA
drlowe@drlowe.com | www.drlowe.com | 303-413-6003

Introduction | Full Paper | AddendaErrors in Quotations from Dr. Guttler
Clarifications
| Selected Response Letters | pdf format

Addendum 1
Fibromyalgia


We can’t doubt what Dr. Guttler believes about the relationship of fibromyalgia symptoms to thyroid disease; he’s hurled judgment down to us in the style of a sovereign’s edict: About fibromyalgia, he wrote, "There is no relationship between that entity and Hypothyroidism. End of story."
[7] (Italics mine.)

Dr. Guttler issued this authoritarian decree without even attempting to refute a substantial body of research—one that shows the main underlying causes of fibromyalgia symptoms to be hypothyroidism and thyroid hormone resistance. I summarize below what’s contained in that body of research.

Many researchers have noted that fibromyalgia symptoms are virtually identical to those of hypothyroidism.[56][57][58][59][60][61][62][63][64][65][66][67][68] Indeed, as my collaborator Jackie Yellin, has shown, the most well-documented features of fibromyalgia are exactly the same as features of hypothyroidism (see Table 1).

Studies by several research teams indicate that 90% of fibromyalgia patients have underlying thyroid diseases.[69][70] Studies by researchers in the U.S., France, Germany, and Italy show that these thyroid diseases include primary and central hypothyroidism and cellular resistance to thyroid hormone.[57][71][73][74][75][76][78] It’s important to note, however, that most patients’ fibromyalgia symptoms caused by thyroid disease are compounded by other metabolism-impeding factors. The most common factors are poor diet, nutritional deficiencies, poor physical fitness, and metabolism-impairing drugs.[25]

When fibromyalgia patients receive effective treatment for hypothyroidism or thyroid hormone resistance, most are fully and lastingly freed from their fibromyalgia symptoms. Several open but systematic trials and several blinded studies have shown that metabolic treatment including thyroid hormone completely relieves most patients’ symptoms.[16][72][77][79][80][81][82][83] In another double-blind crossover study, researchers reported a positive therapeutic effect on fibromyalgia from transdermal T3.[14] In a randomized double-blind, placebo-controlled study, clinicians used multiple therapies.[13] In that study, as Peter Warmingham noted in an article titled "Fibromyalgia has been solved,"[12] 90% of the fibromyalgia patients used thyroid hormone and 90% improved. These are the only studies in which patients have largely or fully recovered from fibromyalgia symptoms.

Table 1. Some symptoms and objectively verified abnormalities in both hypothyroidism and fibromyalgia.*

Reduced slow-wave sleep

Irritable bowel syndrome

Reduced HPA axis function

Urinary frequency

Increased pain perception

Increased substance P

Depression

Cognitive dysfunction

Slow muscle relaxation time

Exercise intolerance

Impaired glycolysis

Increased hyaluronic acid

Reduced brain blood flow

Chronic widespread pain

Increased alpha2-adrenergic receptors on platelets

Dysmenorrhea

Reduced serotonin secretion (platelets)

Joint hypermobility

Reduced growth hormone & somatomedin C

Stiffness & swelling

Sicca symptoms

Orthostatic hypotension

Cold intolerance

Paresthesia

Increased mast cells

Anxiety

Fatigue

*From Jackie Yellin’s seminar, Hampshire Hills Sports and Fitness Club, Milford, New Hampshire, Sept. 20, 2001.

If Dr. Guttler doubts the relationship between fibromyalgia symptoms and too little thyroid hormone regulation, he should read three studies by our research team at the Fibromyalgia Research Foundation.[81][82][83] These were double-blind, placebo-controlled, crossover studies. In them, we tested the effects of T3 and placebos on fibromyalgia symptoms. We repeatedly turned the patients’ symptoms off and on by switching them from T3 to placebos, much like turning the flow of water off and on by switching a faucet handle one way and then the other.

We conducted another study that showed that thyroid hormone’s effectiveness at relieving fibromyalgia symptoms isn’t a placebo effect.[15] This study was the first to show long-term effectiveness of a fibromyalgia treatment. The study was a 1-to-5-year follow-up comparing untreated patients to patients treated with metabolic therapy including thyroid hormone. We matched 20 fibromyalgia patients who hadn’t undergone treatment, with 20 fibromyalgia patients who had. We matched them by sex, thyroid status, and the time since their first evaluation.

We first evaluated all the patients 1-to-5 years before the follow-up study began. We compared those baseline measures with the follow-up measures for each group. Treated patients had improved on all measures of fibromyalgia, and they had decreased their drug use. Untreated patients didn’t improve at all, and they were using more drugs. The fact that treated fibromyalgia patients maintained their improvement 1-to-5 years compared to matched untreated patients compels us to formulate a conclusion: Relieving inadequate thyroid hormone regulation produces long-term recovery from fibromyalgia symptoms. The recovery is not due to a placebo effect.

In addition to these studies, a huge body of evidence points to too little thyroid hormone regulation as the main underlying cause of fibromyalgia. For example, compared to other people, the fibromyalgia patient has an extremely high level of substance P in her spinal cord.[84] Substance P is a chemical that amplifies perception of pain.[85][86][87][88] It amplifies pain perception so much that the patient perceives as painful something that ordinarily is not, such as the pressure of a mattress on her back and buttocks.

Thyroid hormone inhibits the production of substance P in the spinal cord.[89][90] When researchers make animals hypothyroid, substance P production is no longer inhibited; the level then rises steeply in the animals’ spinal cords. The high level magnifies the animals’ perception of pain, and like fibromyalgia patients, the animals perceive as painful something that ordinarily is not,[85][86] such as a light squeeze of a rat’s tail. In humans, the increased pain perception is experienced as chronic widespread aches and pains.[91] Such aches and pains, of course, are the main symptoms fibromyalgia.

In our three blinded studies I mention above,[81][82][83] fibromyalgia patients’ pain dramatically decreased or stopped altogether when they took T3. In placebo phases, their pain returned. We assume that the thyroid hormone reduced or stopped our patients’ pain by lowering their substance P levels.

Anyone who understands the molecular biology of thyroid hormone regulation knows that the hormone exerts its metabolic effects largely in two ways: by (1) decreasing the density of alpha2-adrenergic receptors on cell membranes, and (2) increasing the density of beta-adrenergic receptors. These two changes accelerate metabolism.

Studies indicate that fibromyalgia patients have the opposite ratio of receptors: (1) an increased density of alpha2-drenergic receptors,[6] and probably (2) a decreased density of beta-adrenergic receptors.[4] These changes slow the patients’ metabolism. When researchers treated fibromyalgia patients with a drug (salbutamol) that stimulates beta-adrenergic receptors, their symptoms markedly improved.[4] This evidence points directly to too little thyroid hormone regulation as the main underlying mechanism of fibromyalgia.

I could continue citing such evidence for hundreds of pages. I’ve already done that, however, in a 1260-page book titled The Metabolic Treatment of Fibromyalgia. I cited thousands of studies in the book that point directly to inadequate thyroid hormone regulation as the main underlying cause of fibromyalgia symptoms.[25]

Many clinicians and researchers have hypothesized causes of fibromyalgia that differ from the inadequate thyroid hormone regulation hypothesis. With rare exception, these theorists have not, within their hypotheses, accounted for or refuted the massive body of evidence supporting the inadequate thyroid hormone regulation hypothesis; they’ve simply ignored that evidence. Consequently, they’ve violated the first rule of scholarship in formulating their hypotheses. That rule is to know and account for all credible knowledge within the field of study. By violating this rule, they’ve sabotaged their own efforts; their views of fibromyalgia are largely irrelevant to the field and have little if any credibility.

Foremost among these irrelevant and incredible views of fibromyalgia is Dr. Guttler’s, expressed as a dictator’s decree—"There is no relationship between that entity [fibromyalgia] and Hypothyroidism. End of story."[7] (Italics mine.)

Return to Critique

Addendum 2
Blind Faith That Laboratory Thyroid Tests Are Infallible

I’ve extensively studied the scientific literature on thyroid function testing and consulted with many laboratory medicine specialists who are the ultimate experts on the tests. I’ve also written comprehensively on the merits and demerits of the tests.[25] And I’ve undoubtedly ordered and interpreted them for as many patients as Dr. Guttler has. Based on that cumulative experience, I’m convinced that reliably accurate clinical decisions cannot be made solely on the basis of thyroid function test results. I consider clinical decisions of doctors who rely exclusively on the tests to be dubious at best and harmful to many patients at worst.

Dr. Guttler argues that his beliefs about the T4 and TSH tests are scientifically-based. For example, he wrote to Mary Shomon, "Your motto should be We’re patients.... not lab values, we want our doctors to ignore 50 years of research, and treat us like they did in the 1940’s, when therapy was based on symptoms, not facts."[3] Although he suggests that science is the basis of his beliefs, his dogmatic assertions implying that thyroid function tests are infallible are more like evangelism.

In general, the endocrinology specialty shares Dr. Guttler’s dogmatic belief in the infallibility of thyroid function tests. Because of this, I’m fond of collecting published studies in which researchers have documented significant, normal variations in the blood levels of TSH, T4, and T3. In my forthcoming book, Tyranny of the TSH, I include the most representative of these studies. Here, however, I’ll mention only a few to illustrate, contrary to Dr. Guttler’s pronouncements, what science really shows.

In 1997, researchers reported that when they measured patients’ TSH levels week-to-week, the levels did not significantly correlate. The correlation is reported as an "r" value. 1.00 is a perfect correlation, and 0.00 is no correlation whatever. The r value for week-to-week TSH levels was a mere 0.17—just a teensy bit (17%) above no correlation at all. The r value was not statistically significant. This means that the very weak positive correlation week-to-week could have been due merely to chance similarities in the TSH levels, and there may actually have been no correlation at all.[38] Another way of looking at this is that patients’ TSH levels significantly differed week-to-week.

A Japanese researcher studied variations in TSH levels in normal and depressed men and women. He reported, "A large intra-individual variation [variations in the same person] of serum TSH levels determined on different days was found equally in both men and women." He also reported, "The present study demonstrated a large variation of TSH levels in various conditions, even in the same individuals . . . ."[42]

Still other researchers, Weete and colleagues, reported significant variations in the levels of the free T4 and TSH in normal men—levels Dr. Guttler assumes to be impeccably consistent. Variations in the levels of the hormones, however, are of great enough magnitude to lead to misdiagnoses of patients’ thyroid status. The researchers reported that from day to night, men’s TSH levels increased an average of 140%. Their free T4 levels increased by 7%. The researchers also took blood samples every five minutes in a six-to-seven hour period starting between 7 pm and 10 pm. On average, the free T4 level varied by 11%, the free T3 by 15%, and the TSH by 13%. The researchers reported that "a significant regular variation" in the levels of the hormones occurred every 30 minutes.[39]

Aside from natural variations in TSH levels, the levels may vary according to other factors, such as lost sleep or absorption of thyroid hormone into the blood. When normal women were partially deprived of sleep, their TSH concentrations increased significantly. The levels remained high through the following day.[40] Sleep deprivation is so common nowadays that it’s likely that many patients’ TSH levels are tested the day following a night of insufficient sleep. This study suggests that their TSH levels may be higher than they would be following a night of enough sleep. This variation in TSH levels could easily lead doctors to misdiagnoses[25] if they aren’t cognizant of the effect of too little sleep and inquire about it when they test a patient’s TSH level.

After a patient takes a dose of T4, her free T4 level remains elevated for some 9 hours. In patients taking T4-replacement, the T4 level was increased an average of 13%. The TSH level in these patients was decreased by 19%.[41] Obviously, if a patient’s blood is drawn during this 9-hour time, the decision her doctor makes about a dosage adjustment may be quite different from the one he would make if her blood is drawn after the 9-hour period.

Based on this finding, the following scenario is highly likely to occur in the clinic of an endocrinologist. Like a quasi-accountant, this endocrinologist bases his decisions strictly by the numbers—by the patient’s lab test levels.[25]

A man who works out five days a week at a gym comes to the endocrinologist’s clinic complaining of depression, fatigue, and weight gain. The doctor measures the man’s TSH and free T4 levels. His TSH level is 3.05—a hair above the new upper limit according to the American Association of Clinical Endocrinologists. His free T4 is 59.0, which is the lower limit. Based on these levels, the technocratic doctor gives the man a diagnosis of hypothyroidism and attributes his symptoms to a thyroid hormone deficiency. The doctor prescribes a small amount of T4—just enough to lower the man’s TSH level below 3.03 and raise his free T4 slightly.

Contrast the above outcome with the following likely result had the man come in thirty minutes later. The endocrinologist measures the man’s TSH and free T4 levels. As the Weete study found,[39] the TSH may vary 13% every half-hour. In line with this, thirty minutes later the man’s TSH level is 13% less than in the first scenario; it is down from 3.05 to 2.65.

The endocrinologist also measures the man’s free T4 level. Recall that Weete found that men’s free T4 levels varied 11% in thirty-minutes.[39] The man’s level now—thirty minutes later than in the first scenario—is up by 11%; it’s no longer 59.0, but 64.9. Based on these TSH and free T4 levels, the technocratic doctor tells the man that he’s definitely not hypothyroid and that his symptoms must be caused by some other disorder. For the man’s depression, the endocrinologist recommends a psychiatrist; for his fatigue, more sleep; and for his weight gain, more exercise.

The studies I’ve cited in this section should make my point clear: Dr. Guttler’s trust in the perfect consistency of free T4 and TSH levels is misplaced. Over the years, I’ve talked with scores of doctors whom Dr. Guttler would consider "real thyroid doctors." I’ve done so with a keen interest in their approach to diagnosis and treatment of hypothyroid patients. From those conversations, I’ve come to believe that in their clinical decisions, most of these doctors do not allow for factors such as short-time variations in hormone blood levels, too little sleep, or ingestion of thyroid hormone. Because their clinical decisions depend solely on the levels of the two hormones without consideration of other factors, I’ve never trusted their clinical decisions. Nor, for the same reason, could I trust Dr. Guttler’s.

Return to Critique

Introduction | Full Paper | AddendaErrors in Quotations from Dr. Guttler
Clarifications
| Selected Response Letters | pdf format